LIMN
Liminatus Pharma, Inc. Class A Common Stock NASDAQ Listed May 1, 2025$3.73
Pre-mkt
$3.73
+0.00%
Mkt Cap $5.0M
52w Low $3.29
0.3% of range
52w High $141.50
50d MA $4.77
200d MA $15.01
P/E (TTM)
-0.2x
EV/EBITDA
—
P/B
—
Debt/Equity
-0.1x
ROE
104.0%
P/FCF
-8.9x
RSI (14)
52.60
ATR (14)
$0.28
Beta
0.63
50d MA
$4.77
200d MA
$15.01
Avg Volume
39.6K
Liminatus Pharma, Inc. operates as a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is based in LA Palma, California.
CIK (SEC)
Phone
213 273 5453
6 Centerpointe Drive · La Palma, CA 90623 · US
Data updated apr 25, 2026 7:13pm
· Source: financialmodelingprep.com